# Phase 4 Cardiovascular Diseases trials recruiting: 30 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 30 trials in phase 4 for Cardiovascular Diseases that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 Cardiovascular Diseases trials: 30 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/cardiovascular-diseases

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 30
- Recruiting or not yet: 30
- Read on: November 19, 2026

## Trials

The 25 newest of 30, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 1, 2026 | NCT07796217 | Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy | Seoul National University Bundang Hospital | Phase 4 | Recruiting | Cardiac Event, Coronary Artery Disease, Peripheral Artery Disease, Bleeding | 2,758 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07796217) |
| July 13, 2026 | NCT07697833 | Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart Failure Patients | National Institute of Cardiovascular Diseases, Pakistan | Phase 4 | Not yet recruiting | Heart Failure With Reduced Ejection Fraction (HFrEF) | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697833) |
| April 28, 2026 | NCT07554820 | Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With... | Shaikh Zayed Hospital, Lahore | Phase 4 | Recruiting | Rheumatoid Arthritis, Major Adverse Cardiac Events | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07554820) |
| April 2, 2026 | NCT07507409 | Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients | Unity Health Toronto | Phase 4 | Not yet recruiting | Cardiovascular Disease, Surgical Site Infection, Superficial Sternal Wound Infection, Mediastinitis | 401 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07507409) |
| March 19, 2026 | NCT07483801 | DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies | Cambridge University Hospitals NHS Foundation Trust | Phase 4 | Not yet recruiting | Cardiovascular Diseases | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07483801) |
| March 19, 2026 | NCT07482943 | The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure | The University of Hong Kong | Phase 4 | Recruiting | Fontan, Heart Failure, Dapagliflozin, Cardiovascular Diseases, Sodium-GLucose coTransporter-2 Inhibitors | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07482943) |
| January 27, 2026 | NCT07370688 | Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation | Erasmus Medical Center | Phase 4 | Recruiting | Aortic Valve Stenosis, Iron Deficiency, TAVI(Transcatheter Aortic Valve Implantation), Cardiovascular Diseases | 402 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07370688) |
| June 18, 2025 | NCT07026539 | Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes. | University of Aarhus | Phase 4 | Recruiting | Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Disease Due to Type 2 Diabetes Mellitus, Cardiovascular Diseases | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07026539) |
| June 5, 2025 | NCT07007143 | STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant | Chinese Academy of Medical Sciences, Fuwai Hospital | Phase 4 | Recruiting | Mitral Regurgitation | 1,032 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07007143) |
| April 3, 2025 | NCT06909565 | Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary... | Duke University | Phase 4 | Recruiting | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 6,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06909565) |
| March 30, 2025 | NCT06901466 | STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant | Chinese Academy of Medical Sciences, Fuwai Hospital | Phase 4 | Recruiting | Mitral Regurgitation | 880 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06901466) |
| March 12, 2025 | NCT06873321 | VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization | Science Valley Research Institute | Phase 4 | Recruiting | Peripheral Arterial Disease, Venous Thormboembolism, Cardiovascular Diseases, Vascular Surgery Patient with PAD /... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06873321) |
| March 4, 2025 | NCT06856772 | Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Cardiovascular Diseases (CVD), Drug Effect, Atherosclerosis Cardiovascular Disease | 42,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06856772) |
| December 9, 2024 | NCT06722521 | GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification | Asan Medical Center | Phase 4 | Recruiting | Primary Prevention, Vascular Calcification | 7,435 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06722521) |
| November 6, 2024 | NCT06676280 | ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography | Sponsor not shown (see the record) | Phase 4 | Recruiting | Cardiovascular Diseases | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06676280) |
| October 15, 2024 | NCT06642623 | A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients | Yonsei University | Phase 4 | Recruiting | Diabetes Mellitus, Type 2, Cardiovascular Diseases, Kidney Diseases | 2,862 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06642623) |
| October 3, 2024 | NCT06625073 | Randomized Trial of SGLT2i in Heart Transplant Recipients | VA Office of Research and Development | Phase 4 | Recruiting | Heart Transplant, Cardiovascular Disease, Kidney Disease | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06625073) |
| March 28, 2024 | NCT06336317 | Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE | Region Örebro County | Phase 4 | Recruiting | Acute Myocardial Infarction, Cardiovascular Diseases, Inflammatory Response | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06336317) |
| February 28, 2024 | NCT06281665 | Treatment With Aspirin After Preeclampsia: TAP Trial | Sponsor not shown (see the record) | Phase 4 | Recruiting | Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Hypertension, Eclampsia, Gestational Hypertension, Cardiovascular... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06281665) |
| February 16, 2024 | NCT06263452 | Beta-Blocker Influences on Inflammatory and Neural Responses to Stress | University of North Carolina, Chapel Hill | Phase 4 | Recruiting | Cardiovascular Disease | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06263452) |
| October 31, 2023 | NCT06108414 | Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation | China National Center for Cardiovascular Diseases | Phase 4 | Recruiting | Atrial Fibrillation, Anticoagulant Adverse Reaction, Stroke, Major Adverse Cardiac Events | 4,374 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06108414) |
| July 6, 2023 | NCT05932472 | Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial | Sponsor not shown (see the record) | Phase 4 | Recruiting | Atherosclerosis, Cardiovascular Diseases, Drug Effect | 32,706 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05932472) |
| January 26, 2023 | NCT05700877 | Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes | Sponsor not shown (see the record) | Phase 4 | Recruiting | Type 2 Diabetes, Cardiovascular Diseases | 7,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05700877) |
| February 16, 2022 | NCT05242315 | Extended-Release Tacrolimus Following Liver Transplantation | University of Alberta | Phase 4 | Recruiting | Liver Transplant; Complications, Renal Insufficiency, Immunosuppressant Adverse Reaction, Metabolic Syndrome... | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05242315) |
| November 3, 2021 | NCT05105321 | Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP) | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Metabolic Syndrome | 5,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05105321) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 2 |
| Duke University | 2 |
| National Institute of Cardiovascular Diseases, Pakistan | 1 |
| University of North Carolina, Chapel Hill | 1 |
| Shaikh Zayed Hospital, Lahore | 1 |
| Asan Medical Center | 1 |
| Seoul National University Bundang Hospital | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Region Örebro County | 1 |
| University of Alberta | 1 |
| Yonsei University | 1 |
| University of California, San Francisco | 1 |
| The University of Hong Kong | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| VA Office of Research and Development | 1 |
| University of Aarhus | 1 |
| Science Valley Research Institute | 1 |
| University of Chicago | 1 |
| National Heart Centre Singapore | 1 |
| Erasmus Medical Center | 1 |
| Unity Health Toronto | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 7 |
| Denmark | 5 |
| China | 4 |
| South Korea | 4 |
| Canada | 2 |
| Netherlands | 2 |
| United Kingdom | 2 |
| Belgium | 1 |
| France | 1 |
| Switzerland | 1 |
| Pakistan | 1 |
| Sweden | 1 |
| Puerto Rico | 1 |
| Hong Kong | 1 |
| Brazil | 1 |
| Singapore | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Dental hygiene clinics in the United States](https://specstream.ai/data/businesses/dental-hygiene-clinics/united-states)
- [Lawn care companies in the United States](https://specstream.ai/data/businesses/lawn-care-companies/united-states)
- [Software development companies in the United States](https://specstream.ai/data/businesses/software-development-companies/united-states)
- [Beauty product suppliers in the United States](https://specstream.ai/data/businesses/beauty-product-suppliers/united-states)
- [Gardening services in the United States](https://specstream.ai/data/businesses/gardening-services/united-states)
- [Pediatric oncology practices in the United States](https://specstream.ai/data/businesses/pediatric-oncology-practices/united-states)
